GLP-1s Aren't a Substitute for Diet and Lifestyle Changes: Why Eating Less Isn't the Whole Story

GLP-1 medications have changed the landscape of weight management. For many people, these medications can be incredibly helpful, improving blood sugar regulation, reducing appetite, decreasing food cravings, and supporting meaningful weight loss. As a nutrition professional who works with people taking GLP-1 medications, I’m not opposed to these medications, in fact, I see firsthand how beneficial they can be for the right person.

But I do have a concern about the way GLP-1s are often approached.

There is a growing perception that you can continue eating the same way, continue the same lifestyle habits, take a GLP-1 medication, and suddenly the “food noise” disappears, you eat less, and watch the weight melt away. And while reduced food intake is part of how these medications work, eating less is not necessarily the same thing as becoming healthier.

In fact, if we aren't intentional about what is eaten when we're eating less, GLP-1 therapy can create nutritional challenges that may undermine long-term health.

We’re Already Starting With a Nutrient Gap

Before we even talk about GLP-1 medications, we need to recognize the nutritional landscape we’re starting with.

The typical American diet is already falling short of many essential vitamins and minerals, despite providing an abundance of calories. Research using NHANES data has found widespread inadequacy in nutrients such as vitamin D, vitamin E, vitamin C, vitamin A, calcium, magnesium, and potassium. Even some popular “healthy” diet plans can fail to provide adequate amounts of many micronutrients when followed at calorie levels appropriate for weight management, as I discussed in my previous blog post on micronutrient inadequacies in Americans.

Calories provide energy. Nutrients provide the raw materials your body needs to function.

That's an important distinction when we talk about medications that substantially reduce food intake.

When you eat less food, you don't just consume fewer calories. You also consume less protein, iron, calcium, magnesium, potassium, B vitamins, vitamin C, and many other nutrients as well.

And this concern isn't merely theoretical. A recent observational study found that nearly 25% of patients taking a GLP-1 medication developed at least one diagnosed nutritional deficiency within the first year of treatment. Vitamin D deficiency was particularly common. Other research has raised concerns about inadequate intake or status of nutrients including iron, calcium, vitamin B12, and thiamine.

And here's the part that concerns me most: those numbers only reflect deficiencies that were actually diagnosed. What about the people whose nutrient levels aren't being tested? If nobody checks, nobody knows.

Eating Less Can Mean Losing More Than Fat

Another concern is what happens to muscle mass during weight loss.

When someone loses weight, the goal shouldn't simply be to make the number on the scale smaller. Ideally, we want to improve body composition by preserving as much muscle mass⁷ as possible. After all, muscle is our metabolically active tissue that burns calories when we’re at rest and improves insulin sensitivity and glucose uptake. Studies have also shown that longevity⁸ is correlated with the amount of muscle mass someone has.

But significant calorie restriction and weight loss can result in the loss of lean mass. A review ⁹ of studies showed that muscle can represent 15-60% of weight lost in GLP-1 users. This is such a notable concern that the pharmaceutical industry is even developing medications specifically aimed at preserving muscle during pharmacologically induced weight loss. That should tell us something: maintaining muscle mass during weight loss matters.

Consuming adequate protein is one way to preserve muscle during weight loss. Resistance training is another. But if appetite is dramatically suppressed, it can become surprisingly difficult to consume adequate protein to preserve muscle mass, and less muscle can lead to a slower metabolic rate.

Your Body Adapts to Weight Loss

There's another piece of this conversation that often gets overlooked: metabolic adaptation.

When body weight decreases and energy intake is restricted, the body responds. Resting energy expenditure generally decreases with body size, and in some circumstances it can fall beyond what would be predicted solely from changes in body composition. This phenomenon is often referred to as metabolic adaptation or adaptive thermogenesis.

The famous Biggest Loser follow-up study provides a dramatic example. Six years after the competition, participants had regained a substantial amount of the weight they had lost, yet "resting metabolic rates remained significantly lower than expected based on their body composition."⁶

This demonstrates an important physiological principle: your body adapts to weight loss. And when weight loss is accompanied by muscle loss, inadequate protein intake, reduced physical activity, and inadequate nutrient intake, we may be making long-term weight management more difficult.

This is one reason the goal of GLP-1 therapy should not be to simply lose weight. The goal should be to gain health.

A GLP-1 Should Be a Tool, Not the Entire Strategy

If someone takes a GLP-1 primarily to turn off food noise but makes no meaningful changes to their diet, physical activity, protein intake, or muscle-building activity, what happens when they eventually stop taking the medication?

For many people, weight regain¹⁰ occurs after discontinuation. In the STEP 1 trial extension¹¹, participants regained two thirds of the weight they had lost. Anybody considering a GLP-1 should be aware that it is common to regain the weight and prepare with the best diet and lifestyle changes they’re able to make.

Anyone considering a GLP-1 should also be aware that they don’t work for everyone. In fact, emerging research suggests that "as many as 30% of people taking GLP-1 receptor agonists may not achieve at least 5% weight loss," highlighting the substantial variability in individual response.¹

These medications influence several physiological pathways. They increase glucose-dependent insulin secretion, suppress hepatic glucose output, slow gastrointestinal motility, and influence appetite and satiety signaling in the brain. They can therefore improve blood glucose regulation and reduce food intake, among other effects.

But those aren't necessarily the primary drivers of weight gain for every individual.

Metabolic health is complex. Insulin resistance, appetite regulation, sleep, stress, physical activity, body composition, medications, genetics, hormonal factors, gastrointestinal health, and dietary patterns can all play a role. Improving one or two of these factors may be transformative for one person and much less impactful for another.

And then there are the side effects.

Because GLP-1 medications slow gastrointestinal motility, some people experience nausea, vomiting, constipation, diarrhea, gas, bloating, reflux, or other gastrointestinal symptoms. For some, these effects are mild and temporary. For others, they can significantly interfere with health and wellbeing.

What I Want People Taking GLP-1s to Think About

If you're taking a GLP-1 medication and your appetite is smaller, it’s important that you prioritize foods that provide substantial nutrition in relatively small portions:

• Protein: meat, poultry, fish, seafood, eggs, dairy, and other protein-rich foods

• Colorful vegetables: important sources of vitamins, minerals, fiber, and phytonutrients

• Healthy fats: nuts, seeds, avocado, olive oil, and fatty fish

• Nutrient-dense carbohydrates: beans, peas, potatoes, whole grains, fruits, and other minimally processed carbohydrate sources

• Adequate fluids and electrolytes, particularly if nausea, vomiting, diarrhea, or reduced fluid intake is an issue

And don't forget about movement.

Resistance training is particularly important for maintaining muscle during weight loss. Adequate protein and resistance exercise work together to support lean tissue, while regular physical activity can help support metabolic health and physical function.

Depending on the individual, it may also be appropriate to monitor certain laboratory markers during treatment, including vitamin D, iron/ferritin, B12, and magnesium. Nutritional assessment should be personalized based on medical history, diet, symptoms, medications, rate of weight loss, and other risk factors rather than relying on a one-size-fits-all supplement regimen.

My Take on GLP-1s

I believe GLP-1 medications can be incredibly valuable tools for the right person.

But a GLP-1 is not a replacement for diet and lifestyle changes. If anything, nutrition may become more important when you're taking a medication that dramatically reduces how much food you eat.

We're already starting with a population in which nutrient inadequacy is common. Then we introduce a medication that can dramatically reduce food intake, sometimes while also causing nausea, vomiting, constipation, diarrhea, or other gastrointestinal symptoms. If we don't intentionally prioritize protein and micronutrient-rich foods, we may solve one problem while inadvertently creating another.

The goal shouldn't simply be to lose weight. The goal should be to gain health.

That means preserving muscle during weight loss, maintaining adequate nutrition, supporting metabolic health, improving physical function, and building sustainable habits that can continue to support you whether you're taking a medication or not.

A GLP-1 can be one piece of the puzzle. But it shouldn't be the whole puzzle.

Sources:

1. [Study on GLP-1 receptor agonist response variability — approximately 30% of patients not achieving ≥5% weight loss]. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC12664951/

2. [Study on energy intake reduction during GLP-1 treatment]. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC12664951/

3. [2025 observational study of 460,000+ adults on nutritional deficiency diagnoses following GLP-1 initiation]. PubMed. https://pubmed.ncbi.nlm.nih.gov/40584822/

4. [2026 narrative review on micronutrient intake and status during GLP-1 therapy]. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC12664951/

5. [Research on lean mass reduction associated with GLP-1-based weight loss]. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC12664951/

6. Fothergill E, Guo J, Howard L, et al. "Persistent metabolic adaptation 6 years after 'The Biggest Loser' competition." Obesity. 2016. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC4989512/

7. Srikanthan P, Karlamangla AS. "Muscle Mass Index as a Predictor of Longevity in Older Adults." Am J Med. 2014. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC4035379/

8. Wannamethee SG, et al. "Relation of body fat mass and fat-free mass to total mortality: results from 7 prospective cohort studies." PubMed. https://pubmed.ncbi.nlm.nih.gov/33437985/

9. Neeland IJ, et al. "Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies." PubMed. https://pubmed.ncbi.nlm.nih.gov/38937282/

10. Aronne LJ, et al. "Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial." JAMA. https://jamanetwork.com/journals/jama/fullarticle/2812936

11. Wilding JPH, et al. "Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension." PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC9542252/

Related reading: Laura Duffy Nutrition. "GLP Medications and the Return of 'Old' Deficiency Diseases: A Growing Concern." https://www.lauraduffynutrition.com/post/glp-medications-and-the-return-of-old-deficiency-diseases-a-growing-concern